Cargando…

Difference in Profiles of the Gut-Derived Tryptophan Metabolite Indole Acetic Acid between Transplanted and Non-Transplanted Patients with Chronic Kidney Disease

Background: Uremic toxins have emerged as potential mediators of morbidity and mortality in patients with chronic kidney disease (CKD). Indole-3-acetic acid (IAA, a tryptophan-derived uremic toxin) might be a useful biomarker in patients with CKD. The objectives of the present study were to (i) desc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liabeuf, Sophie, Laville, Solène M., Glorieux, Griet, Cheddani, Lynda, Brazier, François, Titeca Beauport, Dimitri, Vanholder, Raymond, Choukroun, Gabriel, Massy, Ziad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139556/ https://www.ncbi.nlm.nih.gov/pubmed/32188143 http://dx.doi.org/10.3390/ijms21062031

Ejemplares similares

Does kidney transplantation influence a form of discrimination for antihypertensive drugs prescriptions?
por: Cheddani, Lynda, et al.
Publicado: (2021)

Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
por: Liabeuf, Sophie, et al.
Publicado: (2018)

Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
por: Liabeuf, Sophie, et al.
Publicado: (2013)

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
por: Laville, Solène M., et al.
Publicado: (2021)

Drugs associated with incident fragility fractures in kidney transplant recipients
por: Batteux, Benjamin, et al.
Publicado: (2022)

Less arterial stiffness in kidney transplant recipients than chronic kidney disease patients matched for renal function
por: Cheddani, Lynda, et al.
Publicado: (2020)

Risk Factors for Early Graft Failure and Death After Kidney Transplantation in Recipients Older Than 70 Years
por: Lemoine, Mathilde, et al.
Publicado: (2019)

Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients
por: Fourdinier, Ophélie, et al.
Publicado: (2019)

Evaluation of Changes Over Time in the Drug Burden and Medication Regimen Complexity in ESRD Patients Before and After Renal Transplantation
por: Marienne, Justine, et al.
Publicado: (2020)

Plasma Exchange in the Management of Catastrophic Antiphospholipid Syndrome
por: Titeca-Beauport, Dimitri, et al.
Publicado: (2016)

Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease
por: Desjardins, Lucie, et al.
Publicado: (2013)

Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease
por: Neirynck, Nathalie, et al.
Publicado: (2012)

Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review
por: Pluquet, Maxime, et al.
Publicado: (2022)

The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
por: Bennis, Youssef, et al.
Publicado: (2019)

What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
por: Vanholder, Raymond, et al.
Publicado: (2022)

The intestine and the kidneys: a bad marriage can be hazardous
por: Vanholder, Raymond, et al.
Publicado: (2015)

The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients
por: de Oliveira, Rodrigo Bueno, et al.
Publicado: (2013)

The Role of Gut-Derived, Protein-Bound Uremic Toxins in the Cardiovascular Complications of Acute Kidney Injury
por: Caillard, Pauline, et al.
Publicado: (2022)

Syndecan-1 and Free Indoxyl Sulfate Levels Are Associated with miR-126 in Chronic Kidney Disease
por: Fourdinier, Ophélie, et al.
Publicado: (2021)

Association between Uremic Toxin Concentrations and Bone Mineral Density after Kidney Transplantation
por: Batteux, Benjamin, et al.
Publicado: (2020)

Glomerulonephritis with non-Randall-type, non-cryoglobulinaemic monoclonal immunoglobulin G deposits (PGNMID and ITG)
por: Fourdinier, Ophélie, et al.
Publicado: (2022)

What is new in uremic toxicity?
por: Vanholder, Raymond, et al.
Publicado: (2008)

The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2015)

Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
por: Lenglet, Aurélie, et al.
Publicado: (2013)

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
por: Vanholder, Raymond, et al.
Publicado: (2018)

p-Cresyl Sulfate
por: Gryp, Tessa, et al.
Publicado: (2017)

Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis
por: Deltombe, Olivier, et al.
Publicado: (2015)

Contribution of Hypoalbuminemia and Anemia to the Prognostic Value of Plasma p-Cresyl Sulfate and p-Cresyl Glucuronide for Cardiovascular Outcome in Chronic Kidney Disease
por: Verbeke, Francis, et al.
Publicado: (2022)

Early steroid withdrawal has a positive effect on bone in kidney transplant recipients: a propensity score study with inverse probability-of-treatment weighting
por: Batteux, Benjamin, et al.
Publicado: (2020)

Gut Microbiota Metabolite Indole Propionic Acid Targets Tryptophan Biosynthesis in Mycobacterium tuberculosis
por: Negatu, Dereje Abate, et al.
Publicado: (2019)

Determination of tryptophan and its indole metabolites in follicular fluid of women with diminished ovarian reserve
por: Liu, Ahui, et al.
Publicado: (2023)

Gut Microbiota-Derived Tryptophan Metabolite Indole-3-aldehyde Ameliorates Aortic Dissection
por: Huang, Sui-Shane, et al.
Publicado: (2023)

From old uraemic toxins to new uraemic toxins: place of ‘omics’
por: Massy, Ziad A, et al.
Publicado: (2018)

Soluble Tumor Necrosis Factor Receptor 1 and 2 Predict Outcomes in Advanced Chronic Kidney Disease: A Prospective Cohort Study
por: Neirynck, Nathalie, et al.
Publicado: (2015)

Factors influencing kidney transplantation rates: a study from the ERA Registry
por: Boenink, Rianne, et al.
Publicado: (2023)

Consequences of oral antithrombotic use in patients with chronic kidney disease
por: Laville, Solène M., et al.
Publicado: (2021)

Urea levels and cardiovascular disease in patients with chronic kidney disease
por: Laville, Solène M, et al.
Publicado: (2022)

Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD
por: Barba, Christophe, et al.
Publicado: (2020)

Early predictors of one-year mortality in patients over 65 presenting with ANCA-associated renal vasculitis: a retrospective, multicentre study
por: Titeca-Beauport, Dimitri, et al.
Publicado: (2018)

Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease
por: Glorieux, Griet, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ritrt9te617cho40sbril0qflh